Inducible Mouse Models for Cancer Drug Target Validation

Area of Science:

• Oncology
• Genetics
• Pharmacology

Background:

• Genetically-engineered mouse (GEM) models are vital for advancing cancer biology understanding and therapeutic strategy development.
• Faithfully recapitulating human cancer features in GEM models is essential for effective cancer conquest.
• Doxycycline-inducible transgenic mouse models offer temporal control over gene expression in specific tissues.

Approach:

• Utilize doxycycline-inducible GEM models to assess gene dependency in tumor maintenance for target validation.
• Investigate tumor recurrence by analyzing regressed tumors after transgene suppression to understand escape mechanisms.
• Analyze recurrent tumors to gain insights into molecular basis of tumor cell escape from transgene dependence.

Key Points:

• Doxycycline-inducible GEM models enable precise regulation of gene expression for target validation studies.
• These models facilitate the study of tumor recurrence by examining molecular mechanisms of therapeutic escape.
• Insights from these studies can predict clinical therapeutic responses and guide development of novel strategies against recurrent tumors.

Conclusions:

• Doxycycline-inducible transgenic mouse models are significant tools for cancer target validation and tumor recurrence studies.
• This review highlights the importance of these models in advancing cancer research and drug development.
• Understanding tumor recurrence mechanisms through these models can lead to improved patient outcomes and therapeutic strategies.